Internal Medicine, Endocrinology, Diabetes, & Metabolism · Columbus, GA
NPI
1548302201
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2425 Brookstone Centre Pkwy
Columbus, GA, 31904
Phone (706) 322-1700
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
53,704 services
Medicare patients, 2024
437
Average age 72
Drug cost, 2024
$3.2M
8,438 prescriptions
Company payments, 2025
$10K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven B Leichter was code J1071 (injection, testosterone cypionate, 1 mg), 51,970 times for 20 patients. In total Steven B Leichter billed 53,704 services in 22 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 51,970 | 20 | $0.02 | $929 |
| 99214 Office E&M - Established | Office | 919 | 400 | $83.48 | $77K |
| 96372 Injection Administration | Office | 361 | 23 | $9.78 | $3,531 |
| 99211 Office E&M - Established | Office | 140 | 85 | $15.72 | $2,201 |
| 95250 Test - Miscellaneous | Office | 107 | 56 | $91.38 | $9,778 |
| 99215 Office E&M - Established | Office | 60 | 55 | $122.67 | $7,360 |
| 99204 Office E&M - New | Office | 53 | 53 | $107.95 | $5,721 |
| 99212 Office E&M - Established | Office | 23 | 23 | $35.18 | $809 |
| 99205 Office E&M - New | Office | 19 | 19 | $136.53 | $2,594 |
| 99213 Office E&M - Established | Office | 13 | 12 | $63.79 | $829 |
By year: 2022 $119K for 37,867 services; 2023 $113K for 45,309 services; 2024 $111K for 53,704 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 202 | 152 | $3.19 | $645 |
| 83036 Blood Count | 12 | 11 | $9.52 | $114 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven B Leichter prescribed most often to Medicare patients was Levothyroxine Sodium, with 495 prescriptions and refills. In total Steven B Leichter wrote 8,438 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 495 | 1,404 | 143 | $5,994 |
| Atorvastatin Calcium Generic | 455 | 1,264 | 140 | $5,891 |
| Jardiance Empagliflozin | 441 | 984 | 120 | $568K |
| Metformin Hcl Generic | 398 | 1,123 | 122 | $2,561 |
| Calcitriol Generic | 305 | 889 | 102 | $9,173 |
| Losartan Potassium Generic | 293 | 866 | 100 | $2,343 |
| Pravastatin Sodium Generic | 288 | 837 | 92 | $4,463 |
| Metformin Hcl Er Metformin Hcl | 270 | 730 | 100 | $3,035 |
| Ozempic Semaglutide | 269 | 449 | 61 | $421K |
| Amlodipine Besylate Generic | 263 | 736 | 91 | $1,455 |
| Acarbose Generic | 188 | 496 | 72 | $10K |
| Ezetimibe Generic | 185 | 510 | 62 | $4,846 |
| Tresiba Flextouch U-100 Insulin Degludec | 155 | 317 | 43 | $93K |
| Rybelsus Semaglutide | 148 | 267 | 36 | $242K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 147 | 380 | 63 | $18K |
Brand drugs: 3,034 claims; generic drugs: 5,121 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven B Leichter $10K ($8,344 in general payments such as food, travel and fees and $1,750 for research) from 33 companies. The largest payer was Sanofi-Aventis U.S. LLC with $3,849.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 15 | $3,849 |
| Abbvie Inc. ABBV | 10 | $3,238 |
| Amgen Inc. AMGN | 18 | $475 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $395 |
| Radius Health, Inc. | 13 | $368 |
| Novo Nordisk Inc NVO | 30 | $334 |
| Abbott Laboratories ABT | 17 | $215 |
| Lilly USA, LLC LLY | 10 | $187 |
| Medtronic, Inc. MDT | 3 | $153 |
| Beta Bionics, Inc. BBNX | 1 | $143 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.